Major study challenges long-held fears about acetaminophen and ibuprofen use in babies
A large-scale study of 4,000 infants found no significant difference in the risk of eczema or bronchiolitis between those treated with acetaminophen and those treated with ibuprofen. The findings provide reassurance to parents and healthcare providers regarding the safety of these common pain relievers in the first year of life.
A major new study provides strong reassurance about the use of acetaminophen (paracetamol) and ibuprofen (Advil) during a baby's first year. Researchers found no evidence that either common pain reliever increases the risk of eczema or bronchiolitis, a respiratory illness that often affects young children.
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in